Suppr超能文献

极低胎龄婴儿使用强心剂与脑室内出血、胎龄及芬太尼使用之间的强关联:一项回顾性研究

Strong Association between Inotrope Administration and Intraventricular Hemorrhage, Gestational Age, and the Use of Fentanyl in Very Low Gestational Age Infants: A Retrospective Study.

作者信息

Stathopoulou Theodora, Agakidou Eleni, Paschaloudis Christos, Kontou Angeliki, Chatzioannidis Ilias, Sarafidis Kosmas

机构信息

Department of Neonatology and Neonatal Intensive Care, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Ippokrateion General Hospital, 54642 Thessaloniki, Greece.

出版信息

Children (Basel). 2023 Oct 8;10(10):1667. doi: 10.3390/children10101667.

Abstract

This was a single center, retrospective cohort study designed to evaluate the association between the administration of inotropes to hypotensive very low gestational age infants (VLGAI) and prenatal and neonatal risk factors. Inpatient medical records were reviewed to identify neonates treated with inotropes (treated group) and a control group for comparison. Two hundred and twenty two (222) VLGAI (less than 32 weeks' gestation) were included in the final analysis and were stratified based on timing of treatment with 83 infants (37.4%) and 139 infants (62.6%) in the treated and control groups, respectively. A total of 56/83 (67%) received inotropes for arterial hypotension during the first 3 days (early treatment subgroup) and 27/83 (32.5%) after 3 days of life (late-treated subgroup). Fentanyl, severe intraventricular hemorrhage (IVH), and gestational age (GA) were the risk factors most significantly associated with the need for inotrope use both during the first 3 days of life and the whole NICU stay, before and after adjustment for confounders. In conclusion, fentanyl, severe IVH, and GA are the risk factors most strongly associated with the need for inotrope treatment in VLGAI. Measures to modify these risk factors may decrease the need for cardiovascular medications and improve outcomes.

摘要

这是一项单中心回顾性队列研究,旨在评估对低血压极低胎龄婴儿(VLGAI)使用血管活性药物与产前及新生儿危险因素之间的关联。回顾住院病历以确定接受血管活性药物治疗的新生儿(治疗组)和用于比较的对照组。最终分析纳入了222例VLGAI(妊娠小于32周),并根据治疗时间进行分层,治疗组和对照组分别有83例婴儿(37.4%)和139例婴儿(62.6%)。共有56/83(67%)在出生后前3天因动脉低血压接受血管活性药物治疗(早期治疗亚组),27/83(32.5%)在出生3天后接受治疗(晚期治疗亚组)。在对混杂因素进行调整前后,芬太尼、重度脑室内出血(IVH)和胎龄(GA)是与出生后前3天及整个新生儿重症监护病房(NICU)住院期间使用血管活性药物需求最显著相关的危险因素。总之,芬太尼、重度IVH和GA是与VLGAI使用血管活性药物治疗需求最密切相关的危险因素。改变这些危险因素的措施可能会减少心血管药物的使用需求并改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc50/10605532/cb0684186f39/children-10-01667-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验